Why the study?
Short-duration sit-to-stand tests are used in rehabilitation to address logistical challenges of the 6MWT, but their utility as surrogate measures required evaluation.
Does the 30-second or 60-second sit-to-stand test elicit similar physiological responses to the six-minute walk test in patients with stable HFrEF?
Does the 30-second or 60-second sit-to-stand test elicit similar physiological responses to the six-minute walk test in patients with stable HFrEF?
The 60-second sit-to-stand test elicits similar physiological responses to the 6-minute walk test in HFrEF patients, suggesting its utility as a shorter functional measure in cardiac rehabilitation.
Supports 60-STST as shorter alternative to 6MWT in HFrEF rehabilitation; extends validation of sit-to-stand tests for physiological monitoring.
Background Short-duration sit-to-stand tests are utilised in rehabilitation settings to alleviate logistical challenges associated with the six-minute walk test (6MWT). We assessed the utility of the 30-second sit-to-stand (30-STST) and 60-second sit-to-stand (60-STST) tests as surrogate measures of the 6MWT. Method On separate days, 16 male participants (71 [7] years) with stable heart failure with reduced ejection fraction (36.9 [4.9] %) completed two 6MWT and the 30-STST and 60-STST. Pulmonary gas exchange (oxygen consumption, carbon dioxide production [V˙CO₂], ventilation [V˙E], respiratory exchange ratio, ventilatory equivalent for CO₂ [V˙E/V˙CO₂] and partial pressure of end-tidal CO₂ [PETCO₂]) was measured using a portable metabolic system. Non-invasive haemodynamics (cardiac output, stroke volume, arteriovenous oxygen difference) were measured using impedance cardiography. Mean arterial pressure, heart rate, oxygen saturation and dyspnoea (0–10 scale, arbitrary units) were also monitored. Mixed-effects models (Bonferroni corrected) accounting for time (pre-exercise rest, end-exercise) and test (6MWT, 30-STST, and 60-STST) were used to assess the relation between results observed during each testing modality. Results While PETCO₂ (mean difference [95% confidence interval], −4.9 [−8.9 to −0.8] mmHg), and dyspnoea (1 [0-2] arbitrary units) differed between the 6MWT and 60-STST, no other differences were observed between these tests. In contrast, oxygen consumption (−0.5 [−0.6 to −0.3] L.min⁻¹), V˙CO₂ (−0.5 [−0.7 to −0.4] L.min⁻¹), V˙E (−18.3 [−26.0 to −10.0] L.min⁻¹), PETCO₂ (−5.1 [−9.6 to −0.7] mmHg), cardiac output (−2.4 [−4.9 to −0.3] L.min⁻¹), heart rate (−20 [−33 to −7] beats/min) differed between the 6MWT and the 30-STST, however, no other differences were observed between the 6MWT and the 30-STST. Conclusions Cardiopulmonary, non-invasive haemodynamic and dyspnoea responses differed between the 30-STST and the 6MWT. However, the lack of test-specific differences between the 6MWT and the 60-STST highlights the strong physiological stimulus elicited by this short-duration test modality. The 60-STST has promising utility as a functional measure of heart and lung capacity within cardiac rehabilitation programs.
No takes yet. Share an insight, caveat, or question.
O’Connor et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: